دورية أكاديمية

Genomic analysis of Vibrio cholerae O1 isolates from cholera cases, Europe, 2022.

التفاصيل البيبلوغرافية
العنوان: Genomic analysis of Vibrio cholerae O1 isolates from cholera cases, Europe, 2022.
المؤلفون: Rouard C; Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Vibrions et du choléra, Paris, France., Greig DR; Gastrointestinal Bacteria Reference Unit (GBRU), UK Health Security Agency, London, United Kingdom., Tauhid T; Public Health Agency of Sweden, Unit for Laboratory Surveillance of Bacterial Pathogens, Solna, Sweden., Dupke S; Centre for Biological Threats and Special Pathogens (ZBS 2), National Consultant Laboratory for Human Pathogenic Vibrio species, Robert Koch Institute, Berlin, Germany., Njamkepo E; Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Vibrions et du choléra, Paris, France., Amato E; Norwegian Institute of Public Health, Department of Infection Control and Preparedness, Oslo, Norway., van der Putten B; Centre for Infectious Disease Control, Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Naseer U; Norwegian Institute of Public Health, Department of Infection Control and Preparedness, Oslo, Norway., Blaschitz M; Austrian Agency for Health and Food Safety, Vienna, Austria., Mandilara GD; National Reference Centre for Salmonella, School of Public Health, University of West Attica, Athens, Greece., Cohen Stuart J; Department of Medical Microbiology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Indra A; Paracelsus Medical University of Salzburg, Salzburg, Austria., Noël H; Santé publique France, Saint Maurice, France., Sideroglou T; Directorate of Epidemiological Surveillance and Intervention for Infectious Diseases, National Public Health Organization (NPHO), Athens, Greece., Heger F; Austrian Agency for Health and Food Safety, Vienna, Austria., van den Beld M; Centre for Infectious Disease Control, Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Wester AL; Norwegian Institute of Public Health, Department of Bacteriology, Norwegian Reference Laboratory for Cholera, Oslo, Norway., Quilici ML; Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Vibrions et du choléra, Paris, France., Scholz HC; Centre for Biological Threats and Special Pathogens (ZBS 2), National Consultant Laboratory for Human Pathogenic Vibrio species, Robert Koch Institute, Berlin, Germany., Fröding I; Public Health Agency of Sweden, Unit for Laboratory Surveillance of Bacterial Pathogens, Solna, Sweden., Jenkins C; Gastrointestinal Bacteria Reference Unit (GBRU), UK Health Security Agency, London, United Kingdom., Weill FX; Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Vibrions et du choléra, Paris, France.
المصدر: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Sep; Vol. 29 (36).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE
أسماء مطبوعة: Publication: Stockholm, Sweden : European Centre for Disease Prevention and Control (ECDC)
Original Publication: Saint-Maurice : Hôpital national de Saint-Maurice
مواضيع طبية MeSH: Vibrio cholerae O1*/genetics , Vibrio cholerae O1*/isolation & purification , Vibrio cholerae O1*/classification , Cholera*/microbiology , Cholera*/epidemiology , Phylogeny* , Anti-Bacterial Agents*/pharmacology, Humans ; Europe/epidemiology ; Whole Genome Sequencing ; Microbial Sensitivity Tests ; Genome, Bacterial ; Genomics ; Virulence/genetics ; Drug Resistance, Bacterial/genetics
مستخلص: BackgroundThe number of cholera cases reported to the World Health Organization (WHO) in 2022 was more than double that of 2021. Nine countries of the WHO European Region reported 51 cases of cholera in 2022 vs five reported cases in 2021.AimWe aimed to confirm that the Vibrio cholerae O1 isolates reported by WHO European Region countries in 2022 belonged to the seventh pandemic El Tor lineage (7PET). We also studied their virulence, antimicrobial resistance (AMR) determinants and phylogenetic relationships.MethodsWe used microbial genomics to study the 49 V. cholerae O1 isolates recovered from the 51 European cases. We also used > 1,450 publicly available 7PET genomes to provide a global phylogenetic context for these 49 isolates.ResultsAll 46 good-quality genomes obtained belonged to the 7PET lineage. All but two isolates belonged to genomic Wave 3 and were grouped within three sub-lineages, one of which, Pre-AFR15, predominated (34/44). This sub-lineage, corresponding to isolates from several countries in Southern Asia, the Middle East and Eastern or Southern Africa, was probably a major contributor to the global upsurge of cholera cases in 2022. No unusual AMR profiles were inferred from analysis of the AMR gene content of the 46 genomes.ConclusionReference laboratories in high-income countries should use whole genome sequencing to assign V. cholerae O1 isolates formally to the 7PET or non-epidemic lineages. Periodic collaborative genomic studies based on isolates from travellers can provide useful information on the circulating strains and their evolution, particularly as concerns AMR.
References: Emerg Infect Dis. 2023 Oct;29(10):2072-2082. (PMID: 37735743)
Microb Genom. 2019 Mar;5(3):. (PMID: 30810520)
Front Public Health. 2019 Aug 16;7:228. (PMID: 31475130)
Emerg Infect Dis. 2021 Nov;27(11):2927-2931. (PMID: 34670657)
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7730-E7739. (PMID: 27849586)
N Engl J Med. 2020 Aug 13;383(7):687-689. (PMID: 32786196)
J Comput Biol. 2012 May;19(5):455-77. (PMID: 22506599)
Bioinformatics. 2006 Nov 1;22(21):2688-90. (PMID: 16928733)
Trop Med Infect Dis. 2023 May 06;8(5):. (PMID: 37235314)
Nat Commun. 2020 Oct 22;11(1):5347. (PMID: 33093464)
Emerg Infect Dis. 2023 Aug;29(8):1687-1690. (PMID: 37352549)
Infect Immun. 2016 Aug 19;84(9):2473-81. (PMID: 27297393)
Science. 2017 Nov 10;358(6364):785-789. (PMID: 29123067)
Genomics. 2013 Nov-Dec;102(5-6):500-6. (PMID: 23912058)
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259. (PMID: 30931475)
C R Biol. 2022 May 11;345(1):37-56. (PMID: 35787619)
Genome Biol. 2014 Mar 03;15(3):R46. (PMID: 24580807)
Nature. 2019 Jan;565(7738):230-233. (PMID: 30602788)
Lancet. 2017 Sep 23;390(10101):1539-1549. (PMID: 28302312)
Nature. 2011 Aug 24;477(7365):462-5. (PMID: 21866102)
Nat Microbiol. 2023 Oct;8(10):1787-1798. (PMID: 37770747)
Emerg Infect Dis. 2023 Jan;29(1):149-153. (PMID: 36573719)
mBio. 2015 Apr 21;6(2):. (PMID: 25900650)
Nat Commun. 2023 Mar 1;14(1):1154. (PMID: 36859426)
Science. 2017 Nov 10;358(6364):789-793. (PMID: 29123068)
Nat Commun. 2024 Aug 13;15(1):6963. (PMID: 39138238)
N Engl J Med. 2022 Dec 22;387(25):2387-2389. (PMID: 36449726)
Nucleic Acids Res. 2015 Feb 18;43(3):e15. (PMID: 25414349)
فهرسة مساهمة: Keywords: 2022; Cholera; Europe; Vibrio cholerae; microbial genomics; surveillance; whole-genome sequencing
المشرفين على المادة: 0 (Anti-Bacterial Agents)
تواريخ الأحداث: Date Created: 20240906 Date Completed: 20240906 Latest Revision: 20240910
رمز التحديث: 20240910
مُعرف محوري في PubMed: PMC11378513
DOI: 10.2807/1560-7917.ES.2024.29.36.2400069
PMID: 39239731
قاعدة البيانات: MEDLINE
الوصف
تدمد:1560-7917
DOI:10.2807/1560-7917.ES.2024.29.36.2400069